AARON MARTINEZ: Open Payments
NPI 1740785013 · OBERLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 17 payments from 10 companies in 2025. Trend: 2023 $482 · 2024 $1,322 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Braeburn Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $29 |
| Indivior Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
Products named: GVOKE HYPOPEN, TRELEGY ELLIPTA, BRIXADI, SUBLOCADE, FANAPT, ImmunoCAP, Wegovy, MOUNJARO.
Industry payments across OH — which companies pay providers there.
